Compounds > fluorodeoxyglucose f18
Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Central Nervous System Infection

fluorodeoxyglucose f18 has been researched along with Central Nervous System Infection in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, KY; Lee, MH; Su, YY; Tsai, SF; Tseng, JR; Yen, TC1
Djaldetti, R; Lotan, I; Luckman, J; Siegal, T; Steiner, I1

Other Studies

2 other study(ies) available for fluorodeoxyglucose f18 and Central Nervous System Infection

ArticleYear
Clinical usefulness of FDG PET/CT in the detection of unusual central nervous system infections.
    Journal of the neurological sciences, 2014, Oct-15, Volume: 345, Issue:1-2

    Topics: Aged; Central Nervous System Infections; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed

2014
A 66-year-old patient with progressive left hemiparesis: question.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2014, Volume: 21, Issue:11

    Topics: Acute Disease; Aged; Brain Stem Neoplasms; Central Nervous System Infections; Cerebellar Neoplasms; Demyelinating Diseases; Diagnosis, Differential; Disease Progression; Encephalomyelitis; Fluorodeoxyglucose F18; Glioblastoma; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Paresis; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed

2014